Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (121-130 of 509) with videos related to

Pageof 51
Sort By:
AIDS (London, England)|June 17, 2004
Is the male genital tract really a sanctuary site for HIV? Arguments that it is notSelwyn H Lowe, Sanjay U C Sankatsing, Sjoerd Repping, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2020
Frequency, Risk Factors, and Mediators of Frailty Transitions During Long-Term Follow-Up Among People With HIV and HIV-Negative AGEhIV Cohort ParticipantsEveline Verheij, Ferdinand W Wit, Sebastiaan O Verboeket, et al.
AIDS (London, England)|December 23, 2015
Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the NetherlandsEsther A N Engelhard, Colette Smit, Ard Van Sighem, et al.
Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
Journal of Hepatology|May 27, 2005
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patientsAlfredo Alberti, Nathan Clumeck, Simon Collins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2009
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppressionLars Peters, Amanda Mocroft, Vincent Soriano, et al.
Antiviral Therapy|July 1, 2010
Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatmentShuangjie Zhang, Ard van Sighem, Luuk Gras, et al.
Journal of Colloid and Interface Science|May 7, 2022
Halide anions engineered ionic liquids passivation layer for highly stable inverted perovskite solar cellsXinmeng Zhuang, Xinfu Chen, Lin Xu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2014
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort studyJudith Schouten, Ferdinand W Wit, Ineke G Stolte, et al.
AIDS (London, England)|August 19, 2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew N Phillips, Bruno Ledergerber, Andrezej Horban, et al.
Pageof 51

Showing results (121-130 of 509) with videos related to

Sort By:
Pageof 51
AIDS (London, England)|June 17, 2004
Is the male genital tract really a sanctuary site for HIV? Arguments that it is notSelwyn H Lowe, Sanjay U C Sankatsing, Sjoerd Repping, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2020
Frequency, Risk Factors, and Mediators of Frailty Transitions During Long-Term Follow-Up Among People With HIV and HIV-Negative AGEhIV Cohort ParticipantsEveline Verheij, Ferdinand W Wit, Sebastiaan O Verboeket, et al.
AIDS (London, England)|December 23, 2015
Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the NetherlandsEsther A N Engelhard, Colette Smit, Ard Van Sighem, et al.
Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
Journal of Hepatology|May 27, 2005
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patientsAlfredo Alberti, Nathan Clumeck, Simon Collins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2009
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppressionLars Peters, Amanda Mocroft, Vincent Soriano, et al.
Antiviral Therapy|July 1, 2010
Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatmentShuangjie Zhang, Ard van Sighem, Luuk Gras, et al.
Journal of Colloid and Interface Science|May 7, 2022
Halide anions engineered ionic liquids passivation layer for highly stable inverted perovskite solar cellsXinmeng Zhuang, Xinfu Chen, Lin Xu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2014
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort studyJudith Schouten, Ferdinand W Wit, Ineke G Stolte, et al.
AIDS (London, England)|August 19, 2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew N Phillips, Bruno Ledergerber, Andrezej Horban, et al.
Pageof 51